These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39034799)

  • 1. [China clinical practice guideline for stage Ⅳ primary lung cancer (2024 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):595-636. PubMed ID: 39034799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical practice guideline for stage Ⅳ primary lung cancer in China (2023 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):1-30. PubMed ID: 36709116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical practice guideline for stage Ⅳ primary lung cancer in China(2021 version)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2021 Jan; 43(1):39-59. PubMed ID: 33472316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical practice guideline for stage Ⅳ primary lung cancer in China(2020 version)].
    Chinese Association for Clinical Oncologists
    Zhonghua Zhong Liu Za Zhi; 2020 Jan; 42(1):1-16. PubMed ID: 32023763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical practice guideline for multi-disciplinary team diagnosis and treatment of stage Ⅳ primary lung cancer in China].
    ;
    Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):667-672. PubMed ID: 35880332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2022 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):457-490. PubMed ID: 35754224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):539-574. PubMed ID: 37460438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)].
    ;
    Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(27):2037-2074. PubMed ID: 37455124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical practice guideline for lympoma in China (2021 Edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):707-735. PubMed ID: 34289565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical practice guideline for brain metastases of lung cancer in China (2021 version)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):269-281. PubMed ID: 33752305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chinese guideline for clinical diagnosis and treatment of malignant pleural mesothelioma (2021 Edition)].
    Multidisciplinary Committee of Oncology, Chinese Physicians Association
    Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):383-394. PubMed ID: 33902201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2021 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):591-621. PubMed ID: 34289551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer (2019 edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):257-287. PubMed ID: 32375445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guideline for the diagnosis and treatment of gallbladder carcinoma (2019 edition)].
    ;
    Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):243-251. PubMed ID: 32241052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comprehensive guidelines for the diagnosis and treatment of pancreatic cancer (2020 version)].
    Pancreatic Cancer Committee of Chinese Anticancer Association
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):81-100. PubMed ID: 33378799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [China clinical practice guideline for epidermal growth factor receptor tyrosine kinase inhibitors in stage Ⅳ non-small cell lung cancer (version 2023)].
    ;
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(40):3160-3173. PubMed ID: 37879869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical practice guideline for multi-disciplinary treatment strategy of lymphoma in China].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2021 Feb; 43(2):163-166. PubMed ID: 33601479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chinese expert consensus on the multidisciplinary clinical diagnosis and treatment of stage Ⅲ non-small cell lung cancer (2019)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):881-890. PubMed ID: 31874543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study.
    Barni S; Maiello E; Di Maio M; Ardizzoni A; Cappuzzo F; Maranzano E; Novello S; Bennati C; Ori A; Rizzoli S; Crinò L;
    Lung Cancer; 2015 Nov; 90(2):234-42. PubMed ID: 26314614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.